2008
DOI: 10.3390/molecules13102570
|View full text |Cite
|
Sign up to set email alerts
|

Recent Synthetic Approaches Toward Non-anomeric Spiroketals in Natural Products

Abstract: Many natural products of biological interest contain [6,5]- and [6,6]-spiroketal moieties that can adopt various configurations, benefiting or not from anomeric conformation stabilizing effects. The spiroketal fragments are often important for the biological activity of the compounds containing them. Most stable spiroketal stereoisomers, including those benefiting from conformational anomeric effects (gauche conformers can be more stable than anti conformers because of a contra-steric stabilizing effect), are … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
20
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(21 citation statements)
references
References 72 publications
1
20
0
Order By: Relevance
“…The polyketide chain undergoes all late‐stage enzymatic modifications while it is still tethered either to the last sal PKS extension module at the C terminus of SalAIX or to an auxiliary enzyme 6. Stereospecific spiroketal formation in certain actinomycete polyketides—the antibiotics avermectin19 and reveromycin, for example20—proceeds by dehydrative cyclization of a dihydroxyketone precursor catalysed by a spirocyclase. However, in polyether ionophores such as salinomycin the trigger for spiroacetal formation is the ring opening of epoxide intermediates, catalysed by new epoxide hydrolase/cyclase enzymes of the MonB16 family, and neither the sal gene cluster nor any other cluster for a polyether ionophore encodes an enzyme with sequence similarity to known spirocyclases 19.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The polyketide chain undergoes all late‐stage enzymatic modifications while it is still tethered either to the last sal PKS extension module at the C terminus of SalAIX or to an auxiliary enzyme 6. Stereospecific spiroketal formation in certain actinomycete polyketides—the antibiotics avermectin19 and reveromycin, for example20—proceeds by dehydrative cyclization of a dihydroxyketone precursor catalysed by a spirocyclase. However, in polyether ionophores such as salinomycin the trigger for spiroacetal formation is the ring opening of epoxide intermediates, catalysed by new epoxide hydrolase/cyclase enzymes of the MonB16 family, and neither the sal gene cluster nor any other cluster for a polyether ionophore encodes an enzyme with sequence similarity to known spirocyclases 19.…”
Section: Methodsmentioning
confidence: 99%
“…Various factors might govern the observed ratio of 2 to 3 . In many spiroacetals the configuration at the spiroacetal centre is determined by contributions from anomeric effects, dipole–dipole interactions, opportunities for intramolecular hydrogen‐bonding and steric effects 20. In the salinomycin system there is also a potential contribution from metal binding to the nascent chain, and it cannot be discounted that the specificity and kinetics of subsequent chain release affect the observed product ratios.…”
Section: Methodsmentioning
confidence: 99%
“…Accordingly, with increasing interest for sp 3 -rich molecules, spirocyclic compounds are being considered valuable as molecular platforms for the generation of high-quality small molecule collections, taking advantage of the stereochemical diversity, and of their three-dimensional shape and structural bias to develop lead compounds, specifically in the field of protein-protein interactions [3][4][5][6]. Spiranic rings such as spiroketals are present in numerous natural products [7][8][9], a wide array of spirocyclic compounds are being studied in drug discovery and their chemical space have been systematically charted and characterized recently by Bajorath and co-workers ( Figure 1) [10]. This study revealed that spirocycles are found only in few approved drugs [11] and that there is a significant potential to explore the chemical space of spirocyclic scaffolds, especially in the case of the condensed ones.…”
Section: Introductionmentioning
confidence: 99%
“…Chiral spiroketals are key structural motifs in am ass of natural and synthetic bioactive compounds. [5,6] Among the family of spiroketals,6 ,6-spiroketal behaves as ac rucial pharmacophore in many natural products, [7] and also as an important skeleton in chiral ligands applied in various transition-metal-catalyzed asymmetric reactions (Scheme 1b). [8] In previous works,t he common strategy was to deliver chiral 6,6-spiroketal through intramolecular nucleophilic addition of alcohol to oxocarbenium ion intermediate or carbonyl group catalyzed by chiral Brønsted acids [9] or chiral iridium complexes.…”
mentioning
confidence: 99%